Nanoform small is powerful logo Nanoform small is powerful logo
  • Contact Us
  • About Nanoform
    About Nanoform
    • Vision, mission and values
    • Organization
      Board of Directors
      CEO and Management Team
    • Success stories
    • Corporate Responsibility
  • Technology
  • Services
  • Corporate Governance
    Corporate Governance
    • Corporate Governance Statements
      General meeting
      Extraordinary General Meeting 2020
      Annual General Meeting 2020
      General meetings
    • The Board of Directors
      Board of Directors
      Duties of the Board of Directors
      Authorisations
      Board committees
      Renumeration of the Board
    • CEO and Management Team
      Remuneration
      Audit
      Internal Control and Risk Management
      Code of conduct
    • Articles of Association
      Insider administration
      Disclosure policy
      Transcations of managers
  • Investors
    Investors Investerare Sijoittajat
    • Financial Reports and Presentations
      Press releases
      Subscribe
    • Share and shareholders
      Share information
      Share capital development
      Certified Adviser
      Analyst Coverage
      Ownership structure
      Notifications of major shareholdings
      Manager Transactions
    • IPO
    • Investor calendar
      Contact
    • Finansiella rapporter och presentationer
      Pressmeddelanden
      Prenumerera
    • Aktien och aktieägare
      Aktieinformation
      Aktiekapitalets utveckling
      Certified Adviser
      Analytiker
      Ägarstruktur
      Anmälan om betydande aktieägare
      Transaktioner utförda av personer i ledande ställning
    • Börsnotering
    • Investerarkalender
      Kontakt
    • Taloudelliset raportit ja esitykset
      Tiedotteet
      Tilaaminen
    • Osake ja osakkeeomistajat
      Tiedot osakkeesta
      Osakepääoman kehitys
      Hyväksytty neuvonantaja
      Analyytikot
      Omistusrakenne
      Ilmoitukset merkittävistä osakkeenomistajista
      Johtohenkilöiden liiketoimet
    • Listautuminen
    • Sijoittajakalenteri
      Yhteystiedot
  • Media
    Media
    • Press releases
      News
    • Pharmaceutical events
      Articles & videos
    • Subscribe
    • Contact
  • Careers
  • Contact

Press releases

Press Releases
  • Regulatory Releases
  • All releases
2020
  • 2021
  • 2019
  • 2018
  • All years
All categories
  • Manager Transactions
All languages
  • English
  • Finnish
  • Swedish
Non Regulatory
December 23, 2020

Nanoform included in Nasdaq First North 25 index as of Jan 4th, 2021

Non Regulatory
December 21, 2020

First dosing of nanoformed drug successfully accomplished

Non Regulatory
December 8, 2020

Notification of major shareholdings according to Nanoform’s Articles of Association

Non Regulatory
December 2, 2020

Nanoform makes US TV debut in Advancements with Ted Danson (CNBC)

Non Regulatory
November 16, 2020

Invitation to presentation of Nanoform’s Q3 Report on November 27

Non Regulatory
November 11, 2020

Nanoform to present at Avanza Börsdag on November 18

Non Regulatory
September 1, 2020

Nanoform expands global commercial team with US appointments

Non Regulatory
July 9, 2020

Nanoform’s positive commercial momentum continues

Non Regulatory
June 15, 2020

Nanoform Finland Plc appoints Peter Hänninen as General Counsel

Non Regulatory
May 4, 2020

Nanoform awarded GMP certification

Non Regulatory
April 9, 2020

Nanoform appoints Miguel Calado as Chairman of the Board

Non Regulatory
March 9, 2020

Nanoform and Orion collaborate on next-generation drug development

Non Regulatory
February 10, 2020

Nanoform establishes US subsidiary

Contact us

+358 29 370 0150
info@nanoform.com

  • Privacy Policy
  • Cookies

Subscribe

Read more about our protection of your personal data.

Nanoform Finland Oyj
Cultivator II, Viikinkaari 4
FI-00790 Helsinki
Finland
Company number: 2730572-8

Nanoform uses cookies to ensure that we give you the best experience on our website. Read more about cookies.

Decline Accept